Hyper-IL-6 (Hadassah University Hospital/Hadasit Medical Research Services and Development)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHyper-IL-6 (Hadassah University Hospital/Hadasit Medical Research Services and Development)
Drug Alias NameHyper-IL-6 (Hadassah University Hospital)Hyper-IL-6
ClassificationBiologics
Mechanisms of ActionInterleukin-6 modulatorsIL-6 receptor agonists
TargetsIL-6 receptorInterleukin-6
Therapy Area/IndicationsHeart InjuriesRenal InsufficiencyXerostomia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHadasit Medical Research Services & Development LtdHadassah University Hospital
Active IndicationsN/A
Inactive IndicationsHeart InjuriesRenal InsufficiencyXerostomia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A